Epigenetic modulation of the tumor immune microenvironment by nanoinducers to potentiate cancer immunotherapy

• 作者: Ning Zhang Xishan Hao
• 来源期刊: 癌症生物学与医学（英文版）
• 年，卷（期）: 2022,（1）
• 所属期刊栏目: EDITORIAL
• 页码范围: 1-3
• 页数: 3页
• 语种: 英文
• DOI: 10.20892/j.issn.2095-3941.2021.0514

摘要

Epigenetic dysregulation is a key factor leading to oncogen-esis and tumor progression1. To date, seven agents in three epigenetic target classes have been approved by the U.S. Food and Drug Administration for the treatment of diverse malig-nancies.